Asto CT Secures $56.5M to Revolutionize Equine CT Imaging and Diagnostics

Asto CT is thrilled to announce that the company has successfully raised $56,500,000 in its latest funding round, marking a pivotal moment in the evolution of equine health diagnostics. Since its inception, Asto CT has been committed to enhancing the quality of life for horses and providing peace of mind for their owners by offering safe, high-quality fan-beam imaging solutions. This incredible investment will enable the company to expand its cutting-edge research and further integrate advanced robotics with state-of-the-art medical computed tomography (CT) scanning systems. At the core of Asto CT’s mission is the pursuit of improved diagnostic accuracy and treatment efficacy for equine health, particularly in addressing conditions of the distal limbs and diseases of the head and neck. The new capital fuels the company’s efforts to enhance its robotic imaging technology, which is designed to deliver precise, reliable scans that can catch early signs of troublesome conditions. With this funding, Asto CT also plans to invest in developing a more robust screening infrastructure that will not only elevate current diagnostic capabilities but also set the stage for groundbreaking innovations in veterinary medicine. Furthermore, the company is committed to ensuring that these technological advancements are accessible to equine care providers and horse owners alike, thereby reinforcing their trust in diagnostic accuracy. This funding milestone is a testament to Asto CT’s vision and the confidence that investors have in its mission to transform veterinary diagnostics through innovation and excellence. As the company embarks on this promising new chapter, it continues to lead the way in merging robotics with advanced imaging to offer unprecedented insights into equine health and well-being.